Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy


Posted: 2021-11-04 19:00:00
Review Colloids Surf B Biointerfaces . 2021 Oct 20;209(Pt 1):112163. doi: 10.1016/j.colsurfb.2021.112163. Online ahead of print. Affiliations Expand Affiliations 1 College of Pharmacy, Southwest Minzu University, Chengdu 610041, China. 2 College of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, Sichuan, China. 3 College of Pharmacy, Southwest Minzu University, Chengdu 610041, China. Electronic address: Lili@163.com. 4 NICM Health Research Institute, Western Sydney University, Westmead, Australia. Electronic address: michelle.tianqing.liu@gmail.com. 5 College of Pharmacy, Southwest Minzu University, Chengdu 610041, China. Electronic address: zhixiang-yuan@hotmail.com. Item in Clipboard Review Hongmei Liu et al. Colloids Surf B Biointerfaces. 2021. Show details Display options Display options Format Colloids Surf B Biointerfaces . 2021 Oct 20;209(Pt 1):112163. doi: 10.1016/j.colsurfb.2021.112163. Online ahead of print. Affiliations 1 College of Pharmacy, Southwest Minzu University, Chengdu 610041, China. 2 College of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, Sichuan, China. 3 College of Pharmacy, Southwest Minzu University, Chengdu 610041, China. Electronic address: Lili@163.com. 4 NICM Health Research Institute, Western Sydney University, Westmead, Australia. Electronic address: michelle.tianqing.liu@gmail.com. 5 College of Pharmacy, Southwest Minzu University, Chengdu 610041, China. Electronic address: zhixiang-yuan@hotmail.com. Item in Clipboard CiteDisplay options Display options Format Abstract Mesenchymal stem cells (MSCs) are multipotent stem cells with the capacity to differentiate into several cell types under appropriate conditions. They also possess remarkable antitumor features that make them a novel choice to treat cancers. Accumulating evidence suggest that the MSCs-derived extracellular vesicles, known as exosomes, play an essential role in the therapeutic effects of MSCs mainly by carrying biologically active factors. However, limitations such as low yield of exosomes and difficulty in isolation and purification hinder their clinical applications. To overcome these issues, research on development of exosome-mimics has attracted great attention. This systematic review represents, to the best of our knowledge, the first thorough evaluations of the innate antineoplastic features of MSCs-derived exosomes or exosome-mimics, the methods of drug loading, application as drug delivery system and their impacts on targeted cancer therapy. Importantly, we dissect the commonalities and differences as well as address the shortcomings of work accumulated over the last two decades and discuss how this information can serve as a guide map for optimal experimental design implementation ultimately aiding the effective transition into clinical trials. Keywords: Drug delivery systems; Exosome; Exosome-mimics; Mesenchymal stem cells; Targeted cancer therapy. Copyright © 2021 Elsevier B.V. All rights reserved. Publication types [x] Cite Copy Format: Send To [x]

参考サイト PubMed: exsome



バイオクイックニュース日本語版:エクソソーム特集

バイオクイックニュース日本語版
2月 19, 2021 バイオアソシエイツ

オンチップ生合成したNK細胞由来エクソソームが、非小細胞肺癌に対して抗腫瘍活性を示す

ミシガン大学ローゲル癌センターとミシガン大学工学部の研究者らは、癌と戦うためのナチュラルキラー免疫細胞の配備という新たな治療法の開発の面で一歩進んでいる。この研究者らは、ナチュラルキラー細胞をキャプチャーし、それらに癌を殺す エクソソーム を放出させる最初の体系的な方法を開発した。…

ゲスト 819人 と メンバー 4人 がオンラインです